Zhi Jian Chen
Director/Board Member at Shanghai Haihe Biopharma Co., Ltd.
Profile
Zhi Jian Chen is currently a Director at Huatai Futures Co., Ltd.
and a Director at Shanghai Haihe Biopharma Co., Ltd.
He was previously a Director at Deluxe Family Co., Ltd.
from 2008 to 2012 and a Member-Supervisory Board at Shanghai Nanjiang Group Co. Ltd.
in 2012.
Zhi Jian Chen active positions
| Companies | Position | Start |
|---|---|---|
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Director/Board Member | 01/01/2018 |
Huatai Futures Co., Ltd.
 Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Director/Board Member | 28/12/2010 |
Former positions of Zhi Jian Chen
| Companies | Position | End |
|---|---|---|
| DELUXE FAMILY CO., LTD. | Director/Board Member | 31/05/2012 |
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Director/Board Member | 06/01/2012 |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| DELUXE FAMILY CO., LTD. | Finance |
| Private companies | 3 |
|---|---|
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Finance |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
Huatai Futures Co., Ltd.
Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Finance |
- Stock Market
- Insiders
- Zhi Jian Chen
